Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now

The global genomics market is projected to grow at a 16.5% rate from 2024 to 2030, driven by factors like personalized treatment demand, gene therapy, and rising cancer rates.